04/2009
A Guide to Advances in Pain Management: A Synopsis of Roundtable Discussions
|
Course Objectives
|
|
|
After completion of this activity, participants will be
better able to:
• Identify chronic pain patients who have comorbid
psychiatric disorders
• Formulate strategies to prevent/lessen abuse and/or
diversion when managing pain
• Summarize the clinical trial evidence and clinical
experience of topically applied analgesics
|
|
|
|
top
|
|
|
To Receive A Certificate
|
|
|
|
Review the material in the Course Presentations section.
|
|
|
|
Complete the CME Posttest with a score of 7 out of 10 questions correct.
|
|
|
|
You will then be asked to register and complete a brief course evaluation.
|
|
|
|
A certificate will be automatically generated for you online.
|
|
|
|
|
|
|
|
|
|
Method of Participation
|
|
|
• To receive CME credit, you must complete the
evaluation, post-test, and registration online
• The evaluation provides each participant with the
opportunity to comment on the quality of the
instructional process, the perception of enhanced
professional effectiveness, the perception of commercial
bias, and his or her views on future educational needs.
• A statement of credit will be available for printing online
upon completion of the evaluation.
|
|
|
|
top
|
|
|
|
|
Accreditation
|
|
|
The University of Nebraska Medical Center, Center for
Continuing Education (UNMC CCE) is accredited by the
Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for
physicians.
The UNMC CCE designates this educational activity for a
maximum of 2 AMA PRA Category 1 Credits™. Physicians
should only claim credit commensurate with the extent of
their participation in the activity.
This activity has been planned and implemented in
accordance with the Essential Areas and Policies of the
ACCME through the joint sponsorship of the UNMC CCE
and PharmaCom Group, Inc.
|
|
|
|
top
|
|
|
|
|
|
|
Disclosure
|
|
|
In accordance with the ACCME, the UNMC CCE requires
that any person who is in a position to control the content
of a CME activity must disclose all relevant financial
relationships held with a commercial interest.
Accordingly: the UNMC CCE staff and PharmaCom
Group, Inc, staff who were involved in the development
of this activity have no financial relationships with any
commercial interests that are relevant to this activity.
|
|
|
|
top
|
|
|
|
|
Disclaimer
|
|
|
|
The content and views presented in this educational
activity are those of the faculty and do not necessarily
reflect those of the UNMC CCE or PharmaCom Group,
Inc. This material is prepared based upon a review of
multiple sources of information, but it is not exhaustive of
the subject matter. Therefore, health care professionals
and other individuals should review and consider other
publications and materials on the subject matter before
relying solely upon the information contained in this
educational activity. The reader is also urged to consult
the full prescribing information on any drug mentioned in
this publication for recommended dosages, indications,
contraindications, warnings, precautions, and adverse
effects before prescribing any medication. This is
particularly important when a drug is new or infrequently
prescribed.
|
|
|
|
top
|
|
|
|
|
Off-Label Usage Disclosure
|
|
|
|
This activity contains information about commercial
products/devices that are unlabeled for use or
investigational uses of products not yet approved.
|
|
|
|
top
|
|
